Chronic Myelogenous Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Placental growth factor also plays a role in chronic myeloid leukemia

Placental growth factor also plays a role in chronic myeloid leukemia

QIAGEN to acquire Ipsogen

QIAGEN to acquire Ipsogen

Researchers investigate the role of PlGF in mice with chronic myeloid leukemia

Researchers investigate the role of PlGF in mice with chronic myeloid leukemia

LLS announces four new Academic Concierge partnerships for cancer drug development

LLS announces four new Academic Concierge partnerships for cancer drug development

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

Customizing targeted therapies to each tumor's molecular characteristics may effectively treat cancer

Customizing targeted therapies to each tumor's molecular characteristics may effectively treat cancer

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

Leukemia protein plays a role in Alzheimer's disease

Leukemia protein plays a role in Alzheimer's disease

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

New study sheds light on origins of myeloid leukemia

New study sheds light on origins of myeloid leukemia

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Novel drug holds potential against resistant chronic myeloid leukemia

Novel drug holds potential against resistant chronic myeloid leukemia

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

Scientists identify new treatment target for squamous cell lung cancer

Scientists identify new treatment target for squamous cell lung cancer

Positive outcomes from imatinib trial in both older and younger patients with CML

Positive outcomes from imatinib trial in both older and younger patients with CML

PerkinElmer launches new oncology testing service for cancer patients

PerkinElmer launches new oncology testing service for cancer patients

Cephalon intends to make takeover bid for ChemGenex

Cephalon intends to make takeover bid for ChemGenex

Cancer drug Gleevec may hold promise against scleroderma: Study

Cancer drug Gleevec may hold promise against scleroderma: Study